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ABSTRACTS OF 2nd INTERNATIONAL MEETING ON RABBIT BIOTECHNOLOGY,
Jouy en Josas. France. June 2007.
Rabbit is more and more used as an experimental animal for the study of biological functions and of human diseases. 
The reasons of this development are multiple. Rabbits are closer to human than rodents. Rabbits are larger than 
mice and even rats thus more appropriate for some surgical operations. Cloning in rabbits is now possible and its 
complete genome is about to be sequenced. Moreover, rabbits are being used to produce pharmaceutical proteins at 
an industrial scale. A specifi c domain of rabbit biotechnology has become a reality. Expectedly, the techniques of 
biotechnology should be implemented in future to solve some specifi c problems of rabbit breeding and particularly 
for the struggle against diseases. 
This urged Jianglin Fan to organize in Tsukuba the fi rst meeting on rabbit biotechnology in 2005. This fi rst success 
inclined to pursue the venture. The 2nd meeting thus took place in Jouy en Josas in June 2007. About 20 speakers and 
40 participants attended the two days meeting. A major part of the presentations referred to models, transgenic or not, 
for the study of human diseases. The state of the art in the use of genetic markers, cloning and use of ES cells was 
depicted. The techniques for breed conservation (semen, embryo and ovary freezing) were shown. The summary of 
the presentations and posters are reported in this issue.
An important point is that a community involved in the development of rabbit biotechnology emerged during the 
meeting. It was decided to organize other meetings on rabbit biotechnology in future with the idea of not competing 
with the World Rabbit Meetings but to be complementary. The next rabbit biotechnology meeting should take place 
in China in 2009. 
Rabbit seleCtion and genome
fRom wild Rabbits to inRa stRains: 
genetiC diveRsity of oRYCToLAGUS 
CUniCULUS
bolet g.
INRA. Station d’amélioration génétique des animaux. 
BP52627, F-31326 Castanet Tolosan Cedex. France. 
Gerard.bolet@toulouse.inra.fr
The history of the European rabbit (Oryctolagus 
cuniculus) is well-documented. Fossil data and 
archaeological remains suggest that the species arose in 
the southern half of the Iberian Peninsula and was able 
to extend its range through the Pyrenean barrier into 
Mediterranean France ca. 500,000 years ago. Several 
studies based on mitochondrial DNA polymorphism 
within the rabbit’s native range reveal two highly 
divergent maternal lineages, each with a well-defi ned 
geographical distribution: one lineage occurs in south-
western Iberia and the other in north-eastern Spain, 
France, and in domestic breeds. Domestic rabbit is the 
only domesticated mammal of Western European origin. 
Nowadays, wild and domestic populations still coexist. 
The fi rst step after the antic period lied in hunting or 
keeping wild rabbits in warrens, from the Middle Ages 
to the 17th century. Domestication of rabbits took place 
during the 18th and mainly the 19th centuries. The most 
important step of creation of breeds occurred during 
the fi rst half of the 20th century. Meanwhile, societies 
of breeders were created to maintain and improve 
these breeds. Nowadays, national associations of rabbit 
breeders exist in many European countries; they are 
in charge of the making and updating of the standard 
book of rabbit breeds. Rabbit meat production is 
realised using specialised herds and is mainly based on 
crossbred rabbits obtained from very few commercial 
strains disseminated through pyramidal systems. These 
commercial strains were created from some middle-sized 
breeds (mainly New Zealand White, Californian) and 
few heavy breeds for paternal lines. In a few cases, they 
were crossbred with other breeds or local populations to 
produce synthetic lines. The INRA undertook in 1972 
the creation and the selection of strains intended to be 
used in crossbreeding according to a pyramidal device. 
Two strains (INRA1077 and INRA2066) were more 
specifi cally selected on their prolifi cacy, in the presence 
of a control strain (INRA9077). Now, the INRA is 
released gradually from this role and concentrates 
on the search for new goals and new methods of 
selection, benefi ting from progress in statistical models 
and knowledge of the genome of rabbit. Nowadays, 
the current objectives of selection focus less on the 
increase in the production than on the improvement of 
maternal qualities and adaptation. The new INRA1777 
strain is selected with an index combining litter size 
at birth and young weight at weaning, with a mating 
plan optimized to control the increase of consanguinity. 
INRA selects also new strains for the longevity of the 
females (using survival analysis tools), the homogeneity 
of the weight of the young rabbits at birth (using 
canalising selection), the residual feed consumption,… 
The existence of a microsatellite-based genetic map 
and a fi rst contig database opens new prospects for 
exploration of genetic variability, detection of QTL 
and selection assisted by marker or introgression. The 
evolution of genetic diversity from the wild populations 
to the patrimonial breeds and the selected strains has 
been estimated with microsatellites and other markers. 
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There was no important genetic bottleneck, including 
in the event of strong reduction of genetic number. This 
genetic diversity has to be conserved and exploited: a 
national germplasm cryobank was created. It includes 
13500 rabbit embryos belonging to 49 populations: 9 
patrimonial breeds, 9 lines with particular genotype and 
31 selected populations or strains. 
Rabbit genome mapping tools
Hayes H.*, Mata X.*, rocHaMbeau H. de†, allain d.†, rogel-
gaillard c.‡.
*INRA, UR339 Unité de Génétique biochimique et 
Cytogénétique, F-78350 Jouy-en-Josas. †INRA, UR631 Unité 
d’Amélioration Génétique des Animaux, F-31326 Castanet-
Tolosan. ‡INRA CEA, UMR 314, Laboratoire de Radiobiologie 
et Etude du Génome, Jouy-en-Josas, France. 
claire.rogel-gaillard@jouy.inra.fr
The importance of European rabbit (Oryctolagus 
cuniculus) as a production, pet and laboratory animal 
and the serious lack of genetic and genomic tools for 
this species led the INRA institute to launch a genome-
wide mapping project in 2001. An integrated genetic 
and cytogenetic map was built directly using a strategy 
based on cytogenetically localized microsatellites. 
Rabbit gene-containing BAC clones were isolated using 
similarities between rabbit cDNAs and human genomic 
sequences to design intra-exonic primers suitable for 
BAC library screening. To date, over 250 new genes 
have been mapped by fluorescent in situ hybridisation 
(FISH) along the 23 chromosomes, thus increasing 
twelve-fold the number of genes mapped in rabbit. 305 
microsatellites were isolated either from FISH-mapped 
BAC clones or from a plasmidic genomic library, of 
which 183 were anchored on all the chromosomes except 
OCU21. The microsatellites were used to genotype 187 
animals chosen from three-generation rabbit families 
in which angora and albino characters segregated and 
the number of alleles found for polymorphic markers 
ranged from 2 to 7 (on average 3,3). This genetic map 
comprises 20 linkage groups spanning 2766.6 cM over 
all chromosomes except OCU20, 21 and X and contains 
111 markers, including 104 INRA microsatellites, five 
other microsatellites and the two morphological markers 
angora and albino. Despite its low density, it allowed us 
to map the albino and angora characters on OCU1 and 15, 
respectively. The 2X rabbit genome sequence available 
since 2005 (http://www.ensembl.org/Oryctolagus_
cuniculus/index.html) will be valuable to rapidly 
increase the map density in targeted genomic regions. 
In conclusion, the genomic tools that are now available 
for rabbit include an integrated genetic and cytogenetic 
map, large DNA fragment libraries, a number of cDNAs 
and EST in public databases, a rabbit-man comparative 
map based on reciprocal chromosomal painting refined 
by cytogenetically-mapped genes and a first assembly 
of the genome sequence. Altogether, these tools are 
suitable for genetic, cytogenetic and physical mapping 
as well as sequencing and polymorphism studies. It 
is anticipated that new projects on QTL mapping and 
positional cloning of candidate genes in rabbit will 
soon be developed in both biomedical and zootechnical 
research fields.
CRyopReseRvation of Rabbit 
genetiC ResouRCes by the female 
way
Joly t.
Université de Lyon. UPSP ENVL/Isaralyon, 23 rue Baldassini, 
69364 Lyon cedex07, France. 
thierry.joly@isara.fr
The cryopreservation of rabbit genetic resources can be 
achieved as well as by the male way and the female 
way. Presently, methods of semen and embryos freezing 
are well described and can be routinely used to preserve 
different populations or genotypes by cryobanking. 
In addition to semen freezing, methods of embryo 
preservation allow the saving of mitochondria genome 
and the storing of this biological material with a higher 
level of sanitary status. Moreover, pups can be directly 
obtained one month after embryo transfer without any 
additional backcrossing and an easier genotyping. Most 
of the time, superovulation treatments with pFSH or 
eCG are used to improve the embryo production. For 
the last 15 years, we have implemented a 3 d standard 
protocol using pFSH. With this protocol, 2/3 to 3/4 
of treated females produced 20 to 30 frozen embryos 
according to their genotype and physiological status. 
After embryo thawing and transfer into synchronized 
recipients, around 80% of females delivered at least one 
alive pups. The embryo survival rate (number of pups/
number of embryos transferred) is of about 40% with an 
important variation between 17% to 53% according to 
genotype of the recipients and the rearing environment. 
Presently, the French national cryobank contains more 
than 15000 frozen embryos from 50 different genotypes 
(endangered breeds, commercial strains, transgenic 
lines …). Nowadays, a new method of cryopreservation: 
the ovarian tissue freezing, is being developed to save 
genotypes with a high scientific or genetic value, under 
emergency situation. Today, pups can be obtained 
using recipients grafted with frozen-thawed ovarian 
fragments.
Rabbit embRyo pRoduCtion and 
ConseRvation
Vicente J.s.
Institute for Animal Science and Technology, Polytechnic 
University of Valencia, 46071-Valencia, Spain. 
jvicent@dca.upv.es
Embryo production, conservation and transfer are 
basic tools in both embryo micromanipulation 
and cryopreservation programmes. Nowadays, the 
production of rabbit mature oocytes and embryos in 
vivo are most favourable than in vitro production, 
the superovulatory responses (20 to 40 ovulating 
follicles) allow to obtain a high number of mature 
oocytes and embryos of sufficient quality. In addition, 
the development of oviductal in vivo recovery and 
transfer techniques during the last decade offers new 
opportunities to study the individual response to 
hormonal treatments, for example, and this technique 
improves also the preservation of valuable animals. 
The embryos can be cryopreserved efficiently reaching 
a survival rate about 50% after transfer. However, the 
efficacy of the program depends on several factors, such 
international Meeting on rabbit biotecHnology
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‡griMaud Frères sélection sas, La Corbière, 49450 Roussay, 
France. §Unité mixte de recherche “Biologie du développement 
et reproduction” inra-cnrs-enVa, département “Physiologie 
animale et systèmes d’élevage”, Centre inra de Jouy en Josas, 
78352 Jouy en Josas Cedex, France.
Embryos freezing and transfer represent interesting tools 
for ex-situ conservation of animal genetic resources in 
rabbit species and are also used to produce specific 
pathogens free populations or to store transgenic lines 
producing therapeutics proteins. Actually, no study 
has evaluated the viability of frozen rabbit embryos 
after a long period of storage and therefore the long 
term efficacy of this method. In 1992, embryos of one 
endangered population of rabbit called “Brun Marron de 
Lorraine” were recovered, slowly frozen and stored for 
14 years in liquid nitrogen before assess their viability. 
In September 2006, a total of 134 morulae were thawed 
and transferred on 14 synchronized recipients does of 
which ovulation was induced 50–60 h before transfer. 
After thawing, embryos are mounted in a capillary 
glass and around 10 embryos was transferred into each 
uterine horns by midventral laparotomy way. The in 
vivo development viability of the thawed embryos was 
assessed with the parturition rate and the embryo survival 
rate. Overall, 100% of the synchronized recipient does 
transferred have delivered at least one pup. A total of 
69 live pups were born and the embryo survival rate is 
51.5%, similar to those usually obtained after transfer 
of fresh embryos. So, this study has highlighted that 
the in vivo development capacity of slowly frozen 
embryos is not altered by a long period of storage in 
liquid nitrogen. These techniques of embryos freezing 
and transfer can be efficacy used in French National 
Cryobanking programs to preserve the genetic diversity 
in rabbit species and like an interesting tool for breeds’ 
management.
ovaRian tissue CRyopReseRvation 
in the doe Rabbit: fRom fReezing 
to biRth
neto V., Joly t., salVetti P., leFranc a.c., corrao 
n., guérin P., buFF s.
Université de Lyon, Unité Cryobio - ENVL/ISARA Lyon, 
Ecole Nationale Vétérinaire de Lyon, 1 Avenue Bourgelat, 
69280 Marcy l’Etoile. France.
Ovarian tissue cryopreservation aims to preserve 
simultaneously thousands of immature follicles from 
the ovarian stock. This recent technique may allow 
preserving the animal genetic resources. The objectives 
of this study were (1) to determine the influence of 
different freezing parameters and (2) to validate a 
slow freezing process for the cryopreservation of the 
ovarian tissue in the doe rabbit. A two-level fractional 
experimental design was used to discriminate 5 freezing 
parameters: the nature (DMSO vs. 1,2-PROH) and the 
concentration (1.5M vs. 2M) of the cryoprotectant, the 
nonpenetrating cryoprotectant (sucrose vs. trehalose), 
the equilibration process (1 vs. 3 steps) and the post-
seeding freezing rate (0.3 vs. 2°C/min) were evaluated. 
The morphological analysis of the preantral follicles 
was performed before (control) and after freezing. 
The best combination of freezing parameters was 
finally challenged by orthotopic autograft and in 
as stage of embryos, genotype of donors and recipients. 
Embryo cryopreservation can be used as a tool for the 
establishment of genetic resource banks for preservation 
of biodiversity in both, animal breeding or laboratory 
products (transgenic, clones), protecting against loss 
through diseases or hazards. From a genetic point of 
view, the cryopreservation of inbred strains is useful 
for the establishment of control populations to study the 




Division of Laboratory Animal Science, Analytical Research 
Center for Experimental Sciences, Saga University, 5-1-1 
Nabeshima, Saga 849-8501, Japan. 
kitajims@cc.saga-u.ac.jp
We have been developing several transgenic rabbits 
as human disease models. At Saga University, we 
currently maintain 15 lines from 8 transgenic rabbits. 
For maintenance and conservation of laboratory animals 
as a bioresource, especially mutant and genetically 
modified animals, cryopreservation of sperm and 
embryos is becoming an important technique. In the 
rabbits, several methods of cryopreservation of sperm 
and embryos have been reported. Cryopreservation of 
sperm is more attractive to us than embryos, because 
of the lower cost and simpler techniques of collection, 
freezing and artificial insemination (AI) compared to the 
comparative techniques needed for embryos. Moreover, 
to maintain transgenic rabbit lines, we need only to pay 
attention to single transgene transmission. Therefore, 
the combination of cryopreservation of semen and AI 
appears suited to the maintenance of transgenic rabbits. 
On the other hand, in cases where polygenes contribute 
to the expression of phenotype, embryos can be chosen 
for cryopreservation because the phenotype might 
disappear with just a combination of cryopreservation 
of semen and AI to wild type females. In our facility, 
cryopreservation of sperm has been carried out using 
egg yolk-acetamide extender. We are currently keeping 
in liquid nitrogen more than 800 straws of sperm from 
our transgenic rabbit lines. The motility of post-thawed 
sperm shows 38.4±8.9%. Utilizing our system of 
semen freezing, using 20×106 motile sperms of post-
thawed spermatozoa for AI, we achieved a pregnancy 
rate of 60-80% with a mean litter size of 4-5 pups. If 
we use more than 40×106 motile sperm, we can expect 
performance similar to that of fresh semen. Our system, 
with its combination of cryopreservation of sperm and 
AI appears a useful method to maintain transgenic 
rabbit lines. 
viability of Rabbit embRyos 
afteR 15 yeaRs stoRage in liquid 
nitRogen
salVetti P.*, Joly t.*, boucHer s.†, Hurtaud J.‡, 
renard J.P.§
*Université de Lyon, enVl/isara lyon, unité cryobio, 1 avenue 
Bourgelat, 69280 Marcy l’Etoile, France. †laboVet, zac de 
la Buzenière - BP 539, 85 505 Les Herbiers Cedex, France. 
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and other main arteries. In WHHLCA and WHHLMI 
rabbits, the coronary atheromatous plaques closely 
resemble human coronary plaques. In WHHLMI 
rabbits, myocardial infarction develops spontaneously 
after maturation due to coronary occlusion with 
atheromatous plaque. In addition, WHHLCA and 
WHHLMI rabbits show metabolic syndrome-like 
features. WHHL rabbit family has been used in studies 
of lipid metabolism, atherosclerosis, and development 
of hypocholesterolemic and/or anti-atherosclerotic 
compounds to translate the results into humans. It is 
necessary for translational researches to use animal 
models, which have closely similar characteristics to 
humans about the mechanisms and features of diseases, 
and the effects of drugs, in addition to appropriate body 
size. In conclusion, WHHL rabbit family is useful for 
translational researches about human cardiovascular 
diseases.
metaboliC syndRome-liKe featuRes 
of whhlmi Rabbits
sHioMi M., yaMada s., ito t.
Institute for Experimental Animals, Kobe University School 
of Medicine. 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, 
Japan. 
ieakusm@med.kobe-u.ac.jp
WHHLMI rabbits, which suffer from severe coronary 
atherosclerosis and myocardial infarction despite 
feeding of normal chow, also show metabolic 
syndrome-like features. Therefore, we examined the 
metabolic syndrome-like features of WHHLMI rabbits. 
After 15 h fasting, glucose tolerance test was carried 
out using WHHLMI rabbits aged 9-18 months old. 
The plasma was prepared periodically and measured 
glucose and immunoreactive insulin (IRI) levels. The 
homeostasis assessment insulin resistance (HOMA-
IR) was calculated using fasting blood glucose and IRI 
levels. Plasma lipoprotein levels were examined by 
ultracentrifugation. Small and dense LDL cholesterol 
(sdLDL) levels were assayed with a kit (sdLDL-C 
SEIKEN). Serum C-reactive protein (CRP) levels 
were measured with an ELISA kit. After euthanasia by 
intravascular injection of pentobarbital sodium, weight 
of the visceral fat was measured and surface lesion areas 
of the aorta were measured with a computer assisted 
image analysis. In glucose tolerance test, WHHLMI 
rabbits showed high fasting IRI levels despite normal of 
the plasma glucose levels. Consequently, the HOMA-
IR levels were increased and insulin resistance was 
observed. In WHHLMI rabbits, the HDL cholesterol 
levels were low and the serum triglyceride and sdLDL 
levels were elevated markedly. Fat accumulation 
was marked at the visceral area. Accumulation of 
visceral fat was correlated to fasting blood glucose, 
VLDL-triglyceride, serum free-fatty acids, serum 
CRP, and aortic atherosclerosis. Correlations between 
accumulation of visceral fat and fasting insulin, HOMA-
IR, serum triglyceride, or systolic blood pressure 
measured at the carotid artery under anesthesia were 
suggested. Aortic lesion area was correlated to visceral 
fat accumulation, fasting insulin level, HOMA-IR, and 
serum free fatty acids. Correlations between aortic 
lesion area and abdominal circumference, insulin index 
of glucose tolerance test, or serum CRP level were 
suggested. Present results suggest that the WHHLMI 
vivo resumption of folliculogenesis. Cryopreserved 
fragments from one ovary were grafted to the 
controlateral ovarian pedicle of 16 females. Then 
females were inseminated along 9 months. The 
experimental design showed that 1,2-PROH (P=0.08) 
and trehalose (P=0.07) tends to improve the morphology 
of preantral follicles. The freezing rate seems to have 
the greatest impact on the follicular morphology which 
was improved by the use of a freezing rate of 0.3°C/
min (P<0.01). No significant effect was observed for 
the other freezing parameters. Thus, transplantations 
were performed with ovarian tissues frozen in a 
medium containing 1.5M 1,2-PROH and 0.2M 
trehalose (3 step-equilibration process, seeding then 
0.3°C/min). The proportion of morphologically normal 
follicles was significantly decreased after freezing as 
compared to fresh control (65.8±4.8% vs. 82.6±2.8%; 
P<0.001). Overall, pups were born from females 
grafted with cryopreserved ovarian tissue. The doe 
rabbit ovarian tissue seems to be successfully preserved 
by slow freezing process. Pups born after grafting from 
cryopreserved ovarian tissue enhance the efficiency of 
such protocol. (Grant from region Rhône-Alpes).
noRmal Rabbits as models to 
study human diseases
whhl Rabbit family is suitable foR 
studies of hypeRlipidemia and the 
Related diseases in human.
sHioMi M.*, ito t.
Institute for Experimental Animals, Kobe University School 
of Medicine. 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, 
Japan.
ieakusm@med.kobe-u.ac.jp
According to WHO the World Health Report 2002, 16.7 
million people around the world die of cardiovascular 
diseases each year and this is about one-third of all 
deaths globally. Principally, atherosclerosis and lipid 
disorders are the main causes in cardiovascular diseases. 
In atherosclerosis and lipid disorders, the characteristics 
of rodents including genetically altering mice are 
largely different from humans. Therefore, it is difficult 
to translate the results from mice experiments to humans 
(e.g., effects of hypolipidemic drugs, lipoprotein 
metabolism, atherosclerotic lesions, and others). In 
contrast to rodents, the features of rabbits for those 
parameters closely resemble humans. There are several 
rabbit models for human hyperlipidemia, atherosclerosis, 
and myocardial infarction; e.g. the WHHL rabbit 
family (original WHHL, coronary atherosclerosis-
prone WHHLCA, and myocardial infarction-prone 
WHHLMI rabbits), St. Thomas’ mixed hyperlipidemic 
rabbit, postprandial hypertriglyceridemic rabbit, and 
others. We have developed the WHHL rabbit family. 
WHHL rabbit family shows hypercholesterolemia 
due to deficiency of low-density lipoprotein (LDL) 
receptors and is an animal model for human familial 
hypercholesterolemia. In this strain, LDL accumulates 
in the plasma and the high-density lipoprotein levels 
are extremely low. As a result, atherosclerosis is 
developed spontaneously in the aorta, coronary arteries, 
international Meeting on rabbit biotecHnology
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rabbit is a suitable animal model for human metabolic 
syndrome.
Rabbit model to study immunity 
to papillomaviRus infeCtion
cHristensen n.d, 
Penn State University, College of Medicine, PA 17033, USA.
Papillomaviruses are important human pathogens that 
cause epithelial lesions including skin and mucosal 
warts and associated malignancies. HPV infections 
result in more than 250,000 deaths from cervical cancer 
in women world-wide. The strict species restriction of 
these viruses provides a challenge to research into the 
mechanisms of natural and vaccine-induced immunity 
to these infections in vivo. Several animal models have 
been used to study papillomavirus immunity including 
the domestic rabbit. Our research has focused on two 
tissue-tropic papillomaviruses including cottontail 
rabbit papillomavirus (CRPV) a skin-tropic PV; and 
rabbit oral papillomavirus (ROPV) a mucosotropic PV. 
We have used the rabbit model to induce protective 
neutralizing antibodies upon vaccination with virus-like 
particle (VLP) and other capsid proteins. In addition, 
we have assessed immunity induced by cell-mediated 
responses upon gene-gun-based DNA vaccinations 
in both protective and therapeutic scenarios. Some 
recent model developments include the production of 
an HLA-A2.1 transgenic rabbit line to more accurately 
measure the role of epitope-specific CD8 T-cells in host 
immunity to papillomavirus infections. The transgenic 
rabbits expressed the HLA protein at high levels, and 
HLA-A2.1 restricted rabbit CD8 cells were induced 
in these rabbits. These latter T-cells were detectable 
using tetramer staining technology and specifically 
lysed epitope-pulsed A2-positive target cell lines. We 
conclude that the rabbit is an excellent model to assess 
both natural and induced immunity to papillomavirus 
infections. Improvements to the model are ongoing and 
include a transgenic model to measure CD8 responses 
to papillomavirus infections. We envisage that these 
transgenic rabbits will have utility for assessment of 
immunity to other human pathogens that are permissive 
in rabbits.
the Rabbit model of tubeRCulosis
yuKari c. 
Manabe MD. Johns Hopkins University School of Medicine.
The global epidemic of tuberculosis claims over 2 
million lives yearly. Mycobacterium tuberculosis (Mtb) 
latently infects one-third of the world’s population. An 
improved understanding of the immunopathogenesis 
of latency and reactivation is urgently needed as co-
infection with human immunodeficiency virus (HIV) 
becomes more prevalent in tuberculosis endemic 
regions of the world and multi-drug resistant strains 
emerge. After aerosol infection with Mtb, rabbits form 
caseous lung granulomas which are strikingly similar to 
tuberculous lung lesions in humans. Unlike guinea pigs 
and mice (commonly used animal species) that ultimately 
die after aerosol infection due to multibacillary chronic 
infection, rabbits are relatively resistant to infection 
with Mtb. Using the muzzle-only aerosol system 
developed at USAMRIID, New Zealand white rabbits 
are aerosol-infected with MtbH37Rv. The inhaled 
bacilli initially replicate in the lung. At 5 weeks after 
infection, they formed grossly visible lung granulomas. 
Following the acquisition of specific immunity, both 
the granuloma size and the culturable number of bacilli 
decrease so that by 20-25 weeks after infection only a 
few lesions are visible. This paucibacillary long-term 
infection is consistent with human latency and occurs 
predictably. 60% of the infected rabbits with “latent” 
infection intramuscularly treated with dexamethasone 
will have culturable bacteria in the lungs 5 weeks later. 
After the corticosteroid treatment is discontinued, those 
rabbits with the highest burden of bacteria are at the 
highest risk for an immune reconstitution inflammatory 
syndrome (IRIS) with the return of CD4 T cells. This is 
characterized by large multi-centric caseous lesions in 
the lung. Using flow cytometry, lymphocyte proliferation 
and TNF-alpha intracellular cytokine staining, rabbit 
cellular responses to Mtb antigens can be measured. 
The aerosol model of tuberculosis in rabbits accurately 
recapitulates many of the stages of the human disease. 
Because rabbits are relatively resistant to aerosol 
infection with Mtb compared to mice, the rabbit is 
an attractive model to study latency and reactivation. 
Effective utilization of this resistant animal model 
could lead to new tuberculosis diagnostics as well as 
the elucidation of important correlates of protective 
immunity.
es Cells and Cloning
establishment of Rabbit embRyoniC 
stem Cells
gócza e.*, HiriPi l.*, leMos a.P.c.*, carstea V.b.*, 
Hayes H.†, rogel-gaillard c.‡, Bősze zs.*
*Agricultural Biotechnology Center, Gödöllő, Hungary. 
†Laboratoire de Genetique biochimique et Cytogenetique, 
INRA, Jouy-en-Josas, France. ‡INRA CEA, Laboratoire de 
Radiobiologie et Etude du Génome, Jouy-en-Josas, France. 
bosze@abc.hu
The present use of transgenic rabbits is limited by 
the low efficiency of microinjection and the absence 
of proven embryonic stem cell (ES) lines. We have 
developed a new method for the derivation of a rabbit 
ES like cell line. Rabbit ES like cells grow as tightly 
packed, flat colonies similar to those of human ES 
cell lines and express several markers characteristic of 
human and/or mouse ES cell lines. We have succeeded 
short-term cultivation of alkaline phosphatase positive 
rabbit ES-like cell lines and shown that they express 
Oct4, SSEA-1, Nanog, CD9 and LIFR. Expression of 
LIFR is not detected in rabbit blastocysts. LIFR cDNA 
was isolated from the genital ridge of 13.5 d old rabbit 
embryos and partially sequenced to prepare a probe to 
screen a rabbit BAC library. Two BAC clones were 
identified and used as probes to FISH-map the LIFR 
gene on OCU 11p11.1. We have also demonstrated 
that the rabbit ES like cells could differentiate into 
beating cardiomyocytes by inducing cardiomyocyte 
differentiation with standard rabbit ES cell culturing 
medium without LIF but in the presence of 20% 
France
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fetal calf serum. Towards the aim of creating second-
generation transgenic rabbits, another essential step was 
to develop an efficient method to create rabbit chimeras 
from preimplantation stage embryos. It remains to be 
tested whether these putative embryonic stem cells are 
truly pluripotent and can give rise to viable chimera 
progeny when we introduce them into recipient rabbit 
blastocysts.
gene taRgeting using somatiC 
Cell nuCleaR tRansfeR
du F.*, Xu J.*, zHang J.†, tian X.‡, yang, X.‡, cHen 
y.e.†
*Evergen Biotechnologies, Inc., Storrs, CT 06269, USA. 
†Cardiovascular Center, University of Michigan Medical 
Center, Ann Arbor, MI 48109, USA. ‡Center for Regenerative 
Biology, University of Connecticut, Storrs, CT 06269, USA.
Cardiovascular disease (CVD) is the single most 
common cause of death in the United States and most 
Western countries. Although the study of the CVD 
has greatly benefited from the use of gene-targeted 
transgenic mouse models, these small rodents do not 
accurately reflect human cardiovascular physiology. The 
Rabbit would be an excellent animal model for CVD 
research, considering its many similarities to humans 
in cardiovascular anatomy, physiology, and lipid 
metabolism. However, the production of transgenic/
knock-out (KO) rabbits is hindered by low efficiency of 
traditional DNA microinjection and the unavailability 
of embryonic stem cell lines. We proposed to use 
somatic cell nuclear transfer (NT) and gene-targeting 
technology to produce transgenic KO rabbits as models 
for the study of human CVD and other diseases. Our 
first objective of the study was to prove the feasibility 
of cloning rabbits since rabbit was a difficult species to 
clone. Rabbit oocytes were flushed from the oviducts 
of superovulated donors treated with FSH and hCG. 
Oocyte enucleation was conducted in 10% FBS M199 
and confirmed by fluorescent microscopy. Cumulus 
cells used for nuclear donors were prepared from 
fresh cumulus-oocytes complexes. Donor nucleus was 
transferred into a recipient oocyte by cell fusion. Briefly, 
a small donor cell with the diameter approximately 
15-19 µm was transferred into the perivitelline space 
of an enucleated oocyte; subsequently the somatic cell-
cytoplast pair was fused by applying three direct current 
pulses at 3.2 kV/cm for a duration of 20 µsec/pulse. 
Fused embryos were activated by electrical stimulation 
regime, and subsequently cultured in M199 + 10% FBS 
containing 2.0 mM 6-dimethylaminopurine (DMAP), 
5 µg/mL cycloheximide for 2 h. Cloned embryos 
were cultured for 20-22 h in vitro before transferred 
into pseudopregnant rabbit recipients. Pregnancy was 
monitored by palpation and/or ultrasound on Day 14-16 
post embryo transfer (ET). One full-term but stillborn, 
and one live and healthy clone rabbit was delivered 
on Day 33, and Day 31 post ET, respectively. In the 
following study, we developed a working transfection 
protocol to target the CRP gene in rabbit fibroblast cells. 
Fetal fibroblast cells were chosen because these cells 
were shown to be successfully transfected and used to 
produce transgenic animals in cattle, sheep and pigs. We 
further demonstrated that CRP+/- fibroblasts supported 
a competent preimplantational embryo development 
in vitro. A rate of 21.6% blastocyst development was 
achieved after NT using CRP+/- fibroblast cells. In all 
embryos that were examined, 100% showed the same 
genotype with the donor cells (CRP+/-). Our further study 
will focus on the production of CRP knockout rabbits. 
CRP+/- fibroblast cells will be used for nuclear transfer 
to produce founder clones (CRP+/-). Subsequently, 
homozygous CRP knockout rabbits (CRP-/-) will be 
produced by routine breeding strategy. 
isolation of Rabbit es-liKe Cells 
with human es Cell featuRes
MarKossian s.*, Joly t.†, salVetti P.†, saVatier P.*, 
aFanassieFF M.*. 
*USC INRA/INSERM PrimaStem, INSERM U846, 18 Avenue 
du Doyen Lépine, 69675 Bron Cedex. †Pôle Agrosystèmes, 
Environnement et Production, ISARA, 31 Place Bellecour, 
69288 Lyon Cedex 02.
Our research project aims at isolating and characterizing 
embryonic stem (ES) cell lines from rabbit embryos. 
ES cells are derived from the pluripotent epiblast of 
the peri-implantation embryo. They can self-renew, 
i.e. proliferate indefinetely in vitro while retaining 
pluripotency. Isolation of ES cell lines relies on the 
adaptation of epiblast stem cells to in vitro conditions 
supporting self-renewal. This has only been achieved in 
a limited number of species including mouse, primates 
and chicken. We have isolated and cultivated inner 
cell mass cells of rabbit blastocysts using optimized 
procedures for derivation of primate ES cell lines. 
Theses cultures are performed in presence of FGF2 and 
inactivated mouse embryonic fibroblasts. We routinely 
obtain flat colonies of compact cells with a high nucleus/
cytoplasm ratio and proeminent nucleoli. These cells are 
similar to human ES cells. They are phosphatase alcaline 
positives and express the pluripotency Oct4 gene. 
They proliferate very rapidly and, therefore, require 
passaging every two days. However, they differentiate 
spontaneously after six passages, a phenomenon 
associated with the loss of Oct4 expression. To prevent 
differentiation, we now aim to overexpress transcription 
factors involved in sustaining pluripotency in mouse 
and human ES cells, namely Oct4, Sox2 and Nanog. 
The first strategy makes use of SIV-derived lentiviral 
vectors to overexpress the human cDNAs in the inner 
cell mass cells. The second strategy is based on Tat-
mediated protein transduction which allows reversible 
penetration of transcription factors into blastocyst 
cells. It makes use of the membrane penetration 
property of the Tat protein of HIV and has been shown 
to allow the entry of biologically active proteins into 
mammalian cells, including mouse ES cells, with high 
efficiency. Either strategies should prevent spontaneous 
differentiation of inner cell mass cells in culture and, 
therefore, increase the derivation of self-renewing ES 
cells.
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tRansgeniC models to study 
human and animal diseases
Rabbit as a model foR embRyo 
development
durantHon V.*, leandri r.d.*, arcHilla c.*, Vignal 
c.*, cabau cM.†, Peynot n.*, daniel n.*, cHesné P.*, 
beauJean n.*, cHaVatte-PalMer P.*, renard J.P.* 
*Biology of Development and Reproduction, †Sigena Team. 
INRA 78352 Jouy en Josas Cedex France.
After having played a leading part in physiological 
analyses of early development few decades ago, the 
rabbit embryo was replaced by the mouse model and 
its associated genetic tools in most developmental 
biology studies. In the mouse however an abrupt 
embryonic genome activation (EGA) occurs already 
at the 2 cell stage concomitantly with an extensive 
epigenetic genome remodelling. This remodelling 
takes place several cell cycles ahead of the first cellular 
differentiation events at the blastocyst stage. In most 
other mammals including human, cattle and rabbit, 
EGA spans over several cell cycles and epigenetic 
remodelling is much less pronounced than in the mouse. 
To analyse the molecular mechanisms underlying 
EGA, and to study the consequences of ART (Assisted 
Reproductive Technologies) associated practices on 
embryo transcriptome, we decided to use the rabbit 
embryo as a model. The metabolic needs of this embryo 
are considered to be much closer to the human embryos 
than the mouse ones. Finally rabbit embryos can easily 
be manipulated in vitro and in vivo developed embryos 
are easily available. To analyse regulation of gene 
expression at EGA and during the first differentiation 
events, we developed a “first generation” rabbit cDNA 
array dedicated to early embryogenesis. This array 
displays 2000 ESTs corresponding to unique contigs 
expressed between EGA and blastocyst stage. Screening 
this array with in vivo developed embryos, we obtained 
a first representation of transcriptome variations at EGA 
and first differentiation in this species and identified 
seven clusters of commonly regulated genes. We then 
analysed the molecular consequences of procedures 
associated with ART: in vitro culture, and ICSI. 
Comparing in vivo and in vitro cultured embryos we 
evaluated the effect of in vitro culture in three distinct 
culture media on embryo transcriptome at two key 
developmental stages: EGA and first differentiation. 
The functional consequences of the perturbations we 
observed will now be analysed by following the foetal 
development of these cultured embryos. 
pRolonged qt and sudden death 
in tRansgeniC Rabbit models foR 
long qt syndRome types 1 and 2.
brunner M.*, liu g.‡, odening K.*, Peng X.†, Koren 
g., zeHender M.*
*Innere Medizin III, Universitätsklinik, Hugstetterstr. 55, 
D-79106 Freiburg, Germany. †Department of Comparative 
Medicine, Penn State University, Hershey, PA, USA. 
‡Cardiovascular Research Center, RIH, Brown Medical 
School, Providence, RI, USA. 
brunner@medizin.ukl.uni-freiburg.de
The human Long-QT syndrome (LQTS) is characterized 
by delayed ventricular repolarization, prolonged QT-
interval, ventricular arrhythmia and sudden death. 
Current murine transgenic animal models of LQTS are 
limited by substantial differences in murine and human 
cardiac electrophysiology. We have a created the first two 
transgenic rabbit models for LQTS by overexpressing 
KvLQT1-Y315S (for LQT1) and HERG-G628S (for 
LQT2) transgenes in the rabbit heart under the control 
of the rabbit-ß-MyHC promoter to drive high-level 
expression in the ventricle. Injection of these constructs 
into embryos resulted in two founders; the presence of the 
transgenes and the proteins was confirmed by Southern-
blot and Western-blot analyses. To establish a heart-
rate (HR) correction for the QT-interval, we analysed 
12-lead ECGs of 14 wild-type littermates at the age of 
113.3 ±24.7 d and used linear regression to derive an 
equation that expresses QTc as a % of expected QT at any 
given HR. The age-matched offspring of both founders 
had markedly prolonged QTc (WT: 99.8±8.9%, LQT1: 
119.5±9.2%, LQT2: 115.0±6.2%, both P<0.01 vs. WT). 
Spontaneous ventricular arrhythmias were detectable 
in LQT2 rabbits. Kaplan Meier curves revealed a 
markedly reduced survival of LQT2 rabbits, with a high 
incidence of sudden death (SD): 14 of 34 LQT2-rabbits 
had SD at an average age of 255±62 d compared to 1 
of 51 littermates (P<0.0001). By contrast, survival of 
LQT1 rabbits was similar to that of WT rabbits. We 
observed a gender difference in QTc of LQT1 rabbits. 
In females we observed a gradual increase in the mean 
QTc during development as follows: month 2: 108.5%; 
month 3: 109.9%, month 4: 114.2%, month 6: 120.7%, 
month 7: 122.7%; P<0.001), while no significant 
change of the prolonged QTc after month 2 was seen 
in males. Telemetric monitoring confirmed ventricular 
tachycardia as the cause of death in 2 animals, and 
differences in the RR/QT relationship with a stepwise 
in crease in the slope of linear regression (WT < LQT1 
< LQT2). These first transgenic rabbit models of 
LQT1 and LQT2 resemble the human phenotype with 
a prolonged QTc, gender differences in QTc intervals, 
ventricular arrhythmias and a high incidence of SD in 
LQT2.
tRansgeniC Rabbits to study 
atheRosCleRosis
lagrost l.
INSERM UMR866 – Faculté de Médecine – Dijon, France.
laurent.lagrost@u-bourgogne.fr
Atherosclerosis development is a complex process 
which involves at least two key steps: 1) the recruitement 
of circulating monocytes which enter the vascular wall 
and transform into macrophages, and 2) the oxidation of 
low density lipoproteins (LDL) which can accumulate 
in macrophages, leading to foam cell formation. Over 
the last decades, a number of transgenic animal models 
have been proposed to study atherosclerosis, raising an 
important, yet unanswered question: what is the most 
relevant model to study atherosclerosis? The choice of 
animal models is tightly dependent on the question to be 
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activity, was found to produce a significant increase 
in circulating levels of apoB-containing lipoproteins, 
together with a significant decrease in their vitamin 
E content and antioxidant status. A marked increase 
in aorta atherosclerotic lesions in HuPLTPTg rabbits 
was observed. Overall, recent observations from our 
laboratory contributed to indicate that the nature of 
PLTP action and the predominance of its beneficial 
versus deleterious effects is actually determined by the 
metabolic context.
apobeC-1 as a potential taRget 
foR obesity and type ii diabetes 
tReatment
gaudriault g.*, daViet c.*, senac d.*, Houdebine 
l.M.†, Viglietta c.†, HarosH i.*, 
*ObeTherapy Biotechnology, 4 rue Pierre Fontaine, 91000 Evry, 
France, †INRA Biologie du Développement et Reproduction, 
Bat 440, Institut National de la Recherche Agronomique, 
78352 Jouy-en-Josas Cedex. France.
Many obesity related genes have been proposed as 
targets for the treatment of obesity. However, these 
obesity genes do not provide efficient drug therapy for 
obesity treatment. This is mainly due to the redundancy 
of the biochemical pathway involved in obesity and the 
lack of specificity of the gene targets. Obesity genes 
may have conferred some evolutionary advantages in 
times of shortage of nutrition through efficient energy 
exploitation as proposed by the ‘’thrifty genome’’ theory. 
Nevertheless, when food is abundant and life become 
sedentary, the same genes yield obesity, type II diabetes 
and other obesity-related diseases. It is therefore a 
challenge to identify crucial gene(s) involved in energy 
absorption. Here we suggest apobec-1 as a potential 
target for obesity treatment. The advantage of this 
anti-obesity target; the gene is expressed exclusively 
in the intestine (tissue specific), it is not redundant 
and has a unique deaminase activity responsible for 
fatty acids absorption, contrary to other obesity targets 
which are not specific and usually are redundant. 
Preliminary results: Generation of transgenic rabbits 
expressing human apobec-1 results in obese phenotype, 
a work done in collaboration with INRA. Shut down of 
apobec-1 using RNAi technology should validated this 
target and open new avenues for both obesity treatment 
and target validation in rabbit.
tRansgeniC Rabbit as a model to 
study pRion diseases
sarradin P.*†, Viglietta c.#, lerouX-coyau M.#, 
liMouzin c.†, barc c.*, bertHon P.*, rossignol c.*, 
gatti J.l.‡, belgHazi M.‡, labas V.‡, lantier F.*, 
laude H. §, Houdebine l.M.#
*INRA, UR1282, Infectiologie Animale et Santé Publique, 
IASP, Nouzilly, F-37380, France. †INRA, UE1277, Plate-
Forme d’Infectiologie Expérimentale, PFIE, Nouzilly, 
F-37380, France. ‡INRA-CNRS-Haras Nationaux-Université 
de Tours, UMR6175, Physiologie de la Reproduction et des 
Comportements, PRC, Nouzilly, F-37380, France. §INRA, 
answered, and the selection of one given animal model 
should be mainly governed by the following criteria:
- does it reflect the human situation in terms of lipid 
metabolism and lesion formation?
- what is the initial expression level(s) of studied gene(s) 
as compared to humans, and should it be turned up or 
down?
- what is the tissue specificity of gene expression in 
animals and humans?
For a number of reasons, rabbit has longer been 
recognized as a highly relevant model to study 
atherogenesis:
- unlike rodents in which circulating cholesterol is 
mainly localized in the antiatherogenic high density 
liporoteins (HDL), rabbit, as human, displays elevated 
concentrations of proatherogenic apolipoprotein 
B-containing lipoproteins when fed a high fat/high 
cholesterol diet
- rabbits are highly susceptible to diet-induced 
atherosclerosis
- as in humans, rabbit plasma contains high levels of 
cholesteryl ester transfer protein (CETP), whereas rats 
and mice are CETP-deficient species. 
However, the rabbit still remains perfectible as a model 
to study dyslipidemia and atherosclerosis. In particular, 
it lacks an analogue of apolipoprotein AII and it is an 
hepatic lipase (HL)-deficient species. Moreover, in 
earlier studies, we reported that the rabbit is one of the 
vertebrate species with the lowest level of the plasma 
phospholipid transfer protein (PLTP) which in contrast 
is highly expressed in both rodent and human plasmas. 
PLTP is a secreted protein which has the ability to bind 
and transfer a number of amphipathic compounds, 
including phospholipids, unesterified cholesterol, 
diacylglycerides, vitamin E and lipopolysaccharides. 
Through its interaction with multiple molecules, PLTP 
was found in our laboratory to modulate lipoprotein 
structure, liver metabolism, vascular biology, brain 
physiology and reproductive biology. Whereas the 
overexpression of human PLTP in the mouse with 
naturally high PLTP activity led to constrasting 
observations in terms of lipoprotein metabolism and 
atherosclerosis, PLTP deficiency in PLTP-knocked out 
homozygotes crossbred with hyperlipidemic mouse 
lines came in clear support of a proatherogenic property 
of circulating PLTP. Complementary experiments 
with tissue-specific knocked out of PLTP expression 
revealed that while systemic overexpression of plasma 
PLTP is proatherogenic, macrophage-derived PLTP 
is anti-atherogenic, indicating clearly that the precise 
localisation of PLTP is a major determinant of its 
pro- or anti-atherogenicity. In an attempt to further 
establish the underlying molecular mechanism of 
the relationship between PLTP and atherosclerosis 
(through its ability to transfer cholesterol and vitamin 
antioxidants), and between PLTP and innate immunity 
(through its ability to transfer lipopolysaccharides) in 
a human-like situation (i.e. with naturally high plasma 
CETP activity and elevated levels of apoB-containing 
lipoproteins), we set up the first model of human PLTP 
transgenic (HuPLTPTg) rabbits in collaborative studies 
with the group of Professor Louis-Marie Houdebine 
(INRA, Jouy-en-Josas). Ubiquitous PLTP expression, 
leading to a controlled increase in plasma PLTP 
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Transmissible spongiform encephalopathies (TSEs) 
or prion diseases are a group of neurodegenerative 
diseases, including Creutzfeldt-Jakob disease (CJD) 
or kuru in humans, bovine spongiform encephalopathy 
(BSE) or scrapie in ruminants or transmissible mink 
encephalopathy (TME). They are characterized by the 
accumulation in the nervous tissue of PrPSc, an abnormal 
isoform of a host encoded cellular protein, PrPC or prion 
protein. Interspecies TSE transmission depends mainly 
upon a species barrier closely linked to the sequence 
homology between the host PrPC and the PrPSc in the 
inoculum. Mouse transgenesis has been extensively 
used with various mammalian PRNP genes (encoding 
PrP protein), either on a mouse Prnp+/+ wild type- or 
on a Prnp0/0- background, to overcome this barrier and 
analyse its molecular bases. Rabbit is one of the species 
that exhibit an apparent universal resistance to TSEs. 
None of the attempts to infect rabbit with CJD, kuru, 
ovine scrapie, TME or mouse-adapted-scrapie have 
ever been successful. We show here that transgenic 
rabbits harbouring the scrapie V136R154Q171 allele of the 
ovine PRNP gene became susceptible to scrapie. This 
new animal model, co-expressing a totally resistant and 
a highly susceptible prion proteins, could be of great 
interest for studying TSE pathogenesis and particularly 
the species barrier phenomenon.
tRansgeniC Rabbit milK as a souRCe 
of ReCombinant human tnap
bodrogi l.*, brands r.†, raaben W.‡, seinen W.†, 
baranyi M.*, FiecHter d.‡, Bősze zs.*
*Agricultural Biotechnology Center, Gödöllő-2100, Szent-
Györgyi A. Str.4., Hungary. †IRAS, University of Utrecht, The 
Netherlands. ‡AM-Pharma B.V. Bunnik, The Netherlands. 
bosze@abc.hu
Gram negative sepsis an LPS (lipopolysaccharide) 
mediated disease is a major cause of mortality in 
hospitals. APs (alkaline phosphatases) are promising 
therapeutic agents in the treatment of LPS mediated 
acute and chronic diseases. LPS is dephosphorylated and 
thereby detoxified by placental AP at physiological pH, 
suggesting that APs may be considered as important host 
defense enzymes and LPS is a natural substrate for APs. 
In our earlier experiments calf intestinal AP prevented 
80% of mice from lethal Escherichia coli infection and 
attenuated LPS toxicity in piglets. More recently, bovine 
intestinal AP efficiently attenuated the inflammatory 
response in a polymicrobial secondary peritonitis 
mouse model. Contrary to other alkaline phosphatase 
isozymes, purified tissue non-specific AP (TNAP) is 
not available in sufficient quantities from tissue sources 
to enable the analyses of its efficacy in animal sepsis 
models. In order to investigate, whether TNAP can 
be used in the treatment of Gram negative sepsis, we 
created transgenic rabbits expressing TNAP in their 
milk under the control of the mammary gland specific 
whey acidic protein /WAP/ promoter. Two transgenic 
lines were created by pronuclear microinjection. High 
TNAP activity was measured in the milk of the #932 
founder /about 1000× of normal human serum levels/, 
while in the milk of #949 the activity was one order 
of magnitude lower, but still significantly increased.The 
molecular weight of recombinant protein was compliant 
with the authentic human form. Recombinant human 
TNA, purified from rabbit milk - if its effectiveness is 
confirmed in an animal sepsis model- may be a valuable 
option with important opportunities to treat LPS 
mediated inflammatory responses. 
pRoduCtion of two vaCCinating 
ReCombinant RotaviRus pRoteins 
in the milK of tRansgeniC Rabbits
soler e., le sauX a., guinut F., .Passet b., coHen 
r., Merle c., cHarPilienne a., FourgeuX c., sorel 
V., Piriou a., dubuquoy c., riFFault s., Pillot M., 
riPoll P.J., scHWartz-cornil i., Parez J.n., coHen 
J., Houdebine l.M.
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78352, Jouy-en-Josas, France. †BioProtein Technologies, 
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Rotaviruses are the main cause of infantile viral 
gastroenteritis worldwide leading to approximately 
500,000 deaths each year mostly in the developing 
world. For unknown reasons, live attenuated viruses 
used in classical vaccine strategies were shown to be 
responsible for intussusception (a bowel obstruction). 
New strategies allowing production of safe recombinant 
non-replicating rotavirus candidate vaccine are thus 
clearly needed. In this study, we utilized transgenic 
rabbit milk as a source of rotavirus antigens. Individual 
transgenic rabbit lines were able to produce several 
hundreds of micrograms per mL of secreted recombinant 
VP2 and VP6 proteins in their milk. Viral proteins 
expressed in milk were immunogenic and induced 
a significant reduction in viral antigen shedding after 
muscular injections or gavage in the presence of Freund 
adjuvant and cholera toxin respectively followed by 
a challenge with virulent rotavirus in the adult mouse 
model. Rectal administration of a milk extract enriched 
in VP2 and VP6 in the presence of cholera toxin or 
detoxified LT(R192G) prevented almost completely 
fecal shedding induced by infectious challenge in mice. 
The vaccine generated rotavirus-specific fecal secretory 
IgA, systemic IgG and IgA and a rotavirus-specific Th1 
response. To our knowledge, this is the first report of 
transgenic mammal bioreactors allowing the rapid co-
production of two recombinant viral proteins in milk to 




gfp tRansgeniC Rabbit as a model 
to image oRgans and tissues in 
situ and in vivo 
al-gubory K.H., Houdebine l.M.
Institut National de la Recherche Agronomique (INRA), UMR 
INRA/ENV A/ CNRS Biologie du Développement et de la 
Reproduction, 78352 Jouy-en-Josas Cedex, France. 
Advances in the understanding of animal development 
and physiology require the use of reliable long-term 
fluorescence in vivo imaging methods and technology. 
In recent years, the techniques of fluorescence, which 
use fluorophores and their excitation by laser, have 
contributed to the development of animal imaging in 
vivo. Confocal microscopes that use miniatur1sed optic 
fibres to deliver light and to measure either reflected or 
excited fluorescence light were used to image tissues 
in living animals. However, optic confocal imaging of 
organs and tissues has been limited by the difficulty of 
gaining access to these sites in vivo. Fibred confocal 
fluorescence microscopy (FCFM), also known as Cell-
viZio (Mauna Kea Technologies, France), was recently 
conceived for in vivo imaging. The FCFM is built up 
on an optical principIe of confocal microscopy, which 
is the ability to reject light from out-of-focus planes 
and to provide a clear in-focus image of a thin section 
within the sample. The excitation wavelength at 488 
nm makes FCFM compatible with GFP ttansgenic 
animals. The other main barrier for in vivo imaging is 
that fluorescent dyes must be used to yield stable and 
sufficient signal without causing damage to biological 
tissues. FCFM technologies used to visualise different 
organs and tissues at the cel1ular level in living animals 
were based on the application of exogenous fluorescent 
dyes. However, removal of dyes by the vascular and 
the lymphatic networks, enzymatic degradation and the 
toxicity of the dyes constitute so many limiting factors 
that affect staining in vivo and do not allow reliable and 
continuous fluorescence imaging in vivo. The green 
fluorescent protein (GFP) from the bioluminescent 
jellyfish Aequorea victoria has become the most widely 
used reporter protein in living organisms. The advantages 
of GFP are that its fluorescence is stable and species 
independent, and does not need exogenous substrates 
or cofactors. In the present study, the feasibility of 
FCFM to image in vivo and in situ cel1s expressing 
GFP in organs and tissues of transgenic rabbits was 
investigated. We also used non-transgenic female rabbits 
mated with transgenic males in arder to visualise GFP-
expressing cel1s in the foetal membranes. We choose 
a mutant form of the GFP (enhanced GFP), which 
fluoresces 35-fold more intensely than wild type GFP 
when excited at 488nm. The transgenic animals were 
obtained by the technique of pronuclear microinjection 
of DNA into fertilised rabbit eggs. The DNA construct 
contained the promoter of the ubiquitously expressed 
human EFl alpha gene, the eGFP gene, the P AC 
gene coding for a puromycin resistance protein under 
the control of an internal ribosome entty site and the 
insulator sequence 5’HS4 added before the promoter. 
eGFP gene expression during foetal development has 
been detected with excellent specificity and sensitivity 
pRoduCtion of phaRmaCeutiCal 
pRoteins
pRoduCtion of ReCombinant human 
C1 inhibitoR in milK
salaHeddine M., Mannesse M.
Pharming Technologies b.v., P.O. Box 451, 2300 AL Leiden, 
The Netherlands.
Pharming Technologies B.V. is developing recombinant 
human C1 inhibitor (rhC1INH) produced in the milk 
of transgenic rabbits, as a treatment for acute attacks 
of Hereditary Angioedema. Transgenic rabbit founders 
were generated by microinjection of an expression 
cassette, containing the bovine αs1casein promoter and the C1-INH transgene into fertilized oocytes collected 
from FSH-stimulated New Zealand White donor 
rabbits. Embryos were re-implanted into recipient 
does.  A total of 170 pups were born, 15 of which were 
transgenic. Presence of the transgene was verified by 
PCR. One animal was selected to be the founder of the 
production colonies and was genetically characterized. 
A sperm bank was established by collecting and 
freezing semen from the founder and his transgenic 
offspring. The sperm bank is used to generate genitors 
which are nested in the colonies and used to generate 
production does for replacement and expansion. All 
production animals are housed in SPF-controlled units 
with overpressure, HEPA-filtered air, decontaminated 
water, gamma-irradiated feed and gowning procedures 
for personnel. A health monitoring program is in place 
consisting of physical examination of individual animals 
and frequent screening of the colony for pathogenic 
agents. In principle, female transgenic production 
animals (F4 generation) are mated with non-transgenic 
males every 42 d on a continuous scheme of breeding 
and milking. The amount of milk obtained per animal 
during each milking session can vary from a few grams 
to over 300 g depending on the individual rabbit, the 
rabbit lactation stage, and frequency of milking. Milk 
is collected into plastic bags, stored at 2-8°C until milk 
is skimmed and frozen. A pool of milk is used in the 
purification process of rhC1INH. The pooling is aimed 
at reducing the batch-to-batch variation in glycosylation 
observed during various periods of lactation. Human 
C1 inhibitor is a glycoprotein with six predicted 
sites for N-glycosylation and at least seven sites for 
O-glycosylation. The structures of the N- and O-glycans 
on rhC1INH have been determined by NMR and mass 
spectrometry. RhC1INH contains a broad array of 
N-glycans, made-up of oligomannose-, hybrid- and 
complex-type structures. The complex-type structures 
are mono- or diantennary, mono- or disialylated, and 
some are core- or antenna- fucosylated (Lewis X). 
The O-glycans on rhC1INH are of the core 1-type, 
mono- or disialylated. The glycosylation analysis of 23 
development batches of rhC1INH and three validation 
up-scaled batches as described above demonstrated a 
high level of batch-to-batch consistency, illustrative 
for a robust manufacturing process of this complex 
recombinant therapeutic glycoprotein in the milk of 
transgenic rabbits. 
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by FCFM. Thanks to eGFP expression in different 
organs and tissues, the structural morphologic feature 
of tongue fungiform and filiform papillae, the small 
intestine villi, the colon villi, pancreas, kidney cortex, 
bladder epithelium, lung alveoli, myometrium and 
adipose tissue were clearly identified by FCFM. FCFM 
images are clase to those obtained by standard light 
microscopy after conventional staining. Cell structure, 
such as the shape, size and nuclear/ cytoplasmic ratio 
can be studied. This may allow histological evaluation 
under physio-pathological conditions in intact living 
animals. The ttansgenic rabbits used in the present 
study offer a potential source of tissues endogenously 
label1ed with eGFP. This source of fluorescent tissues 
and the imaging technology described here open up 
new avenues to investigate graft localisation as well 
as investigations of graft morphology and function in 
recipient animals. 
towaRds the CReation of a global 
Rabbit ReseaRCh CenteR
Fan J.
Department of Molecular Pathology, University of Yamanashi, 
Yamanashi, Japan.
In this post-genomic era, we need to elucidate 
physiological and pathophysiological functions of 
each gene using appropriate animal models. Rabbit, 
as emphasized in this symposium, is one of the best 
models for the study of human cardiovascular diseases 
such as atherosclerosis, diabetes, hypercholesterolemia, 
metabolic syndrome. They are not only valuable in 
studying basic science but also extremely important 
for the translational research, which can directly lead 
to the development of diagnostic tools and therapeutic 
strategies. However, compared to mice, the mostly 
common laboratory animal, rabbits suffer from several 
flaws that make them difficult to use. This includes (1) 
high cost for both purchasing and raising, (2) requirement 
of large space, (3) long time of generating genetically 
modified rabbits, (4) less genomic information and 
limited research reagents, etc. To overcome these 
problems, we need to make an effort to set up an 
international collaboration and make a full use of all 
rabbits (including transgenic rabbits). In Japan, we have 
organized such a “rabbit research center” supported by 
three universities (Saga, Kobe and Yamanashi). Through 
this collaboration, we can generate and breed transgenic 
rabbits, collect and stock sperms from different kinds of 
rabbits, and supply rabbit models for many researchers 
all over the world. To make this facility more efficient, 
we are applying for the government research grant 
for the support of this program called “National Bio-
Resource Project”. In this symposium, I will introduce 
our current commitments and hope to have a chance to 
get support from all rabbit researchers.
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The objective of this study was to compare the milk 
yield of transgenic and non-transgenic females, as well 
as histological structure, ultrastructural morphology 
and apoptosis occurrence of rabbit transgenic and non-
transgenic mammary gland tissue during lactation and 
involution. New Zealand White transgenic rabbits (F3 
generation) were obtained by breeding of transgenic 
rabbits bearing a whey acidic protein-human factor 
VIII (WAP-hFVIII) transgene integrated into their 
genome. The amount of rejected milk was measured by 
weight-suckle-weight method at 20th day of lactation, 
the content of milk protein and concentration of 
recombinant human factor VIII (rhFVIII) in transgenic 
and non-transgenic rabbits at three lactations were 
determined. Samples of mammary gland tissue from 
lactation and involution stages were isolated by surgical 
procedures. These samples were analysed for apoptosis 
(TUNEL), for histology (eozin-haematoxyline) and 
ultrastructure (electron microscopy).  Significantly 
higher (t0.05) milk production at day 20
th of third 
lactation was obtained in transgenic females compared 
to non-transgenic ones. Significant differences (t0.05) in content of milk protein (ranged from 10.24 to 10.79 
g/100g in transgenic and from 9.64 to 9.67g/100g in 
non-transgenic females) at the first, second and third 
lactations were found. Concentrations of rhFVIII 
protein in the milk of transgenic rabbit females, 
determined by ELISA ranged between 4-9 µg/mL. No 
rhFVIII protein level was detected in non-transgenic 
rabbit milk samples. The percentage of apoptotic 
cells was significantly higher (t0.01) in non-transgenic comparing with transgenic mammary gland tissues 
(6.5 vs. 2.4%) taken at involution stage. No differences 
were found in the ultrastructural morphology of 
mammary tissue excepting the relative volume of 
mitochondria and vacuoles between transgenic and 
non-transgenic mammary gland epithelium were 
observed. Morphometric analysis of histological 
preparations at involution stage detected a significantly 
higher (t0.05) relative volume of lumen in transgenic animals compared with non-transgenic (60.00±10.35 vs 
46.51±8.41). The transgenic mammary gland epithelium 
at lactation stage showed a significantly lower volume 
of mitochondria (11.8±1.30%) than the non-transgenic 
(19.8±1.40%) mammary gland. At the involution stage, 
a significant difference (t0.05) only in protein globules (5.0±0.60 vs.2.0±0.60%) was found. Our results reveal 
no any negative effect of the mWAP-hFVIII transgene 
expression on the state of mammary gland of transgenic 
rabbit females.

